Tae Hyun Kim

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index436citations19works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(5), BRCA gene mutations in cancer(3), Metabolomics and Mass Spectrometry Studies(3), Cancer Genomics and Diagnostics(3), Cancer, Lipids, and Metabolism(3)

Publications19 total

Breast cancer implant reconstructive surgery and radiotherapy: a retrospective analysis of medical records
Annals of Surgical Treatment and Research·2025Open Access
Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis
PLoS ONE·2024· 16 citedOpen Access
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study
Expert Opinion on Biological Therapy·2024· 2 cited
Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis
Journal of Korean Medical Science·2022· 8 citedOpen Access
Metabolomics-guided global pathway analysis reveals better insights into the metabolic alterations of breast cancer
Journal of Pharmaceutical and Biomedical Analysis·2021· 16 cited
Neurofibromatosis Type 1 with the Development of Pheochromocytoma and Breast Cancer
Internal Medicine·2020· 4 citedOpen Access
Erratum: Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a <i>BRCA1</i> Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
Journal of the Korean Society of Radiology·2020Open Access
<i>Cordyceps militaris</i> Induces Immunogenic Cell Death and Enhances Antitumor Immunogenic Response in Breast Cancer
Evidence-based Complementary and Alternative Medicine·2020· 12 citedOpen Access
Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a <i>BRCA1</i> Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
Journal of the Korean Society of Radiology·2020Open Access
Plasma metabolites as possible biomarkers for diagnosis of breast cancer
PLoS ONE·2019· 105 citedOpen Access
<i>BRCA1/BRCA2</i>Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
Annals of Laboratory Medicine·2019· 121 citedOpen Access
Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy
Breast Cancer·2019· 15 cited
The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer
Journal of Breast Cancer·2019· 38 citedOpen Access
Effect of anthracycline and taxane on the expression of programmed cell death ligand-1 and galectin-9 in triple-negative breast cancer
Pathology - Research and Practice·2018· 21 cited
Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection
Journal of Korean Medical Science·2016· 23 citedOpen Access
Neuroprotective profile of pyruvate against ethanol-induced neurodegeneration in developing mice brain
Neurological Sciences·2013· 13 cited
Molecular Targets for Treatment of Breast Cancer
Journal of Breast Cancer·2009Open Access
Interactions of acetylcholinesterase with caveolin-1 and subsequently with cytochrome c are required for apoptosome formation
Carcinogenesis·2008· 39 citedOpen Access
Changes in natural killer cell activity and prostaglandin E2 levels during the progression of diethylnitrosamine-induced hepatocarcinogenesis in Fischer 344 rats.
Oncology Reports·1998· 3 citedOpen Access

Frequent Co-authors

Anbok Lee(11), Hee Yeon Kim(5), Hye Kyoung Yoon(5), Yunseon Choi(4), Ki Jung Ahn(3), Heunglae Cho(3), Dong‐Hyun Kim(2), Sung Kwang Park(2), SaeGwang Park(2), Xingguo Quan(2), Nguyen Phuoc Long(2), Gi Won Shin(2), Young Mi Park(2), Ha Young Park(2), Young Jin Heo(2), Jin Wook Baek(2), Yoo Jin Lee(2), Byung-In Moon(1), Ji Won Park(1), Yumi Shin(1)